Year: 2019

Stephan Heckers, MD, MSc, said the gift will allow VUMC to map the trajectory of psychosis.

$10 million gift bolsters psychosis research efforts

A $10 million endowed gift will fund translational research, support clinical programs and create an endowed chair within the Department of Psychiatry.

Eng named to GI cancer leadership position at VICC

Cathy Eng, MD, a national and international leader in gastrointestinal medical oncology, is joining Vanderbilt-Ingram Cancer Center (VICC).

Diversity of conference attendees mirrors increasing support for palliative care

More than 80 people attended a Palliative Care Conference in Nashville recently that was led by faculty members of the Palliative Care programs at VUMC and the Nashville VA Medical Center, and VUMC Center for Biomedical Ethics.

By Jill Clendening

From left, Alexander Gelbard, MD, Suman Das, PhD, and Simon Mallal, MBBS, are among a team of researchers searching for the cause of a rare airway disease that almost exclusively affects adult, Caucasian women.

June 13, 2019

Study seeks to expand treatment options for rare airway disease

Armed with $1.2 million in funding from the National Heart, Lung and Blood Institute (NHLBI), researchers at Vanderbilt University Medical Center are searching to understand the cause of a rare airway disease in hopes of developing better treatments.

By Kelsey Herbers

June 13, 2019

Treatment approved for patients with acute graft-versus-host disease

The U.S. Food and Drug Administration (FDA) recently approved ruxolitinib, the first drug for patients with acute graft-versus-host disease (GVHD) who have an inadequate response to steroid treatment. VUMC’s Madan Jagasia, MBBS, MS, MMHC, was a lead investigator of the REACH1 trial that was the basis for the FDA approval.